Direkt zum Inhalt

Aus der ZeitschriftLSR 2/2018 | S. 109–111Es folgt Seite №109

Swiss Invoicing – EU Regulatory Limitations of Distribution Models

Overview and Practical Considerations

I. Introduction

Life science is an industry sector with a strong representation in Switzerland.1 Many international companies in the pharmaceutical, biotechnology and medical device sectors exist in Switzerland. Due to the excellent infrastructure, talent pool and tax system, Switzerland has established itself as a very attractive country for life science companies. Companies operating internationally often…

[…]